Received Dec 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID; COVID; vertigo; I could not really walk very well; severe reaction/potential inflammatory reaction; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2), as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID"; VERTIGO (non-serious), outcome "unknown"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "I could not really walk very well"; INFLAMMATION (non-serious), outcome "unknown", described as "severe reaction/potential inflammatory reaction". The events "covid", "vertigo", "i could not really walk very well" and "severe reaction/potential inflammatory reaction" required physician office visit. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: the patient received the first shot from Pfizer (clarified as Pfizer COVID-19 Vaccine) for COVID when it first came out, and the patient was not able to get any further shots because the patient had a severe reaction, a 6 weeks reaction that provided him/her with a side effect originating in with vertigo that he/she could not really walk very well and the patient was concerned it was going to stay with him/her. According to his/her doctors, a potential inflammatory reaction similar to the heart reactions of some of the shots, not just maybe of Pfizer's but some of the COVID shots and that the inflammation just was transferred instead of to the heart to the brain. The patient received Paxlovid as treatment for covid-19. No follow-up attempts are possible.